文献速递肿瘤 PET/CT

PSMA-RADS 1.0在18F-DCFPyL PET/CT中的观察者间一致性

Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on 18F-DCFPyL PET/CT Imaging.
PubMed 文献 · J Nucl Med · 2018-09-06

本研究前瞻性模拟前列腺癌转诊中心常规工作流程,由2名经验丰富和2名经验不足的读者独立评估50例18F-DCFPyL PET/CT,应用PSMA-RADS 1.0评分。相同靶病灶的PSMA-RADS评分一致性良好(ICC≥0.60),淋巴结一致性优秀(ICC 0.79),整体扫描印象一致性优秀(ICC 0.84),经验丰富读者ICC 0.97显著高于经验不足读者ICC 0.74(P=0.005)。结论认为PSMA-RADS可有效用于与临床沟通并可用于大型前瞻性试验的数据收集。

要点

  • 相同靶病灶的PSMA-RADS评分观察者间一致性良好,ICC≥0.60。
  • 淋巴结的观察者间一致性优秀,ICC为0.79。
  • 整体扫描印象一致性优秀(ICC 0.84),经验丰富读者ICC 0.97显著高于经验不足读者ICC 0.74(P=0.005)。

核心结论

  • PSMA-RADS在本研究中显示出高一致性率,即使在经验水平不同的读者间亦然。
  • 该发现提示PSMA-RADS可有效用于与临床医生沟通,并可实施于大型前瞻性试验的数据收集。

研究设计与样本

  • 前瞻性设置下模拟前列腺癌转诊中心典型临床工作流程,评估18F-DCFPyL PET检查的PSMA-RADS应用。
  • 4名读者(2名经验丰富读者,PSMA靶向PET解读经验>3年;2名经验不足读者,经验<1年)独立评估50例18F-DCFPyL PET/CT研究,所有读者均阅读过PSMA-RADS 1.0初始发表文献。
  • 每例扫描由观察者最多选择5个靶病灶,记录每个靶病灶的PSMA-RADS评分,并给出基于PSMA-RADS的整体扫描印象。

主要发现

  • 各观察者识别的靶病灶数:经验丰富读者1为123个,经验丰富读者2为134个,经验不足读者1为123个,经验不足读者2为120个。
  • 125个靶病灶被至少2名观察者选中;其中58/125(46.4%)被全部4名读者选中同一靶病灶,40/125(32%)被3名读者选中,27/125(21.6%)被2名观察者选中。
  • 相同靶病灶的PSMA-RADS评分观察者间一致性良好,4个、3个和2个相同靶病灶的组内相关系数(ICC)分别≥0.60。
  • 淋巴结的观察者间一致性优秀,ICC为0.79。
  • 基于PSMA-RADS的整体扫描印象观察者间一致性优秀,ICC为0.84;经验丰富读者ICC 0.97 vs 经验不足读者ICC 0.74,差异显著(P=0.005)。

关键数值与推荐

  • PSMA-RADS 1.0建议读者关注最具活性或最大的病灶,但未对靶病灶选择设置特定预设条件。
  • 相同靶病灶PSMA-RADS评分ICC:4个、3个和2个相同靶病灶均≥0.60。
  • 淋巴结ICC为0.79;整体扫描印象ICC为0.84;经验丰富读者ICC 0.97 vs 经验不足读者ICC 0.74(P=0.005)。

临床怎么用

  • 原文结论认为PSMA-RADS可有效用于与临床医生沟通,并可实施于大型前瞻性试验的数据收集。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recently, the standardized reporting and data system for prostate-specific membrane antigen (PSMA)-targeted PET imaging studies, termed PSMA-RADS version 1.0, was introduced. We aimed to determine the interobserver agreement for applying PSMA-RADS to imaging interpretation of 18F-DCFPyL (2-(3-{1-carboxy-5-[(6-18F-fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid) PET examinations in a prospective setting mimicking the typical clinical workflow at a prostate cancer referral center. Methods: Four readers (2 experienced readers (ERs, >3 y of PSMA-targeted PET interpretation experience) and 2 inexperienced readers (IRs, <1 y of experience)), who had all read the initial publication on PSMA-RADS 1.0, assessed 50 18F-DCFPyL PET/CT studies independently. Per scan, a maximum of 5 target lesions was selected by the observers, and a PSMA-RADS score for every target lesion was recorded. No specific preexisting conditions were placed on the selection of the target lesions, although PSMA-RADS 1.0 suggests that readers focus on the most avid or largest lesions. An overall scan impression based on PSMA-RADS was indicated, and interobserver agreement rates on a target lesion-based, on an organ-based, and on an overall PSMA-RADS score-based level were computed. Results: The number of target lesions identified by each observer was as follows: ER 1, 123; ER 2, 134; IR 1, 123; and IR 2, 120. Among those selected target lesions, 125 were chosen by at least 2 individual observers (all 4 readers selected the same target lesion in 58 of 125 [46.4%] instances, 3 readers in 40 of 125 [32%], and 2 observers in 27 of 125 [21.6%]). The interobserver agreement for PSMA-RADS scoring among identical target lesions was good (intraclass correlation coefficient [ICC] for 4, 3, and 2 identical target lesions, ≥0.60, respectively). For lymph nodes, an excellent interobserver agreement was derived (ICC, 0.79). The interobserver agreement for an overall scan impression based on PSMA-RADS was also excellent (ICC, 0.84), with a significant difference for ER (ICC, 0.97) vs. IR (ICC, 0.74) (P = 0.005). Conclusion: PSMA-RADS demonstrated a high concordance rate in this study, even among readers with different levels of experience. This finding suggests that PSMA-RADS can be effectively used for communication with clinicians and can be implemented in the collection of data for large prospective trials.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Werner RA, Bundschuh RA, Bundschuh L, et al. Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on 18F-DCFPyL PET/CT Imaging. J Nucl Med. 2018. PMID: 30190304. doi:10.2967/jnumed.118.217588

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。